カテゴリー： QYResearch, 世界

世界のシャーガス病薬市場 2019年

【英語タイトル】Global Chagas Disease Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X05349）・商品コード：DATA909X05349
・発行会社（調査会社）：QYResearch
・発行日：2019年11月15日（※2024年版があります。お問い合わせください）
・ページ数：113
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、シャーガス病薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、Cz-007、Cz-008、D-121、DNDI-0690、EPLBS-1246、EPLBS-967、その他に、用途別には、病院、診療所、その他にセグメント区分し、シャーガス病薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・シャーガス病薬の世界市場概要
・シャーガス病薬の製造コスト構成分析
・シャーガス病薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・シャーガス病薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・シャーガス病薬のセグメント分析（種類別）
（Cz-007、Cz-008、D-121、DNDI-0690、EPLBS-1246、EPLBS-967、その他）
・シャーガス病薬のセグメント分析（用途別）
（病院、診療所、その他）
・シャーガス病薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（AstraZeneca Plc、Bayer AG、Daiichi Sankyo Co Ltd、Eisai Co Ltd、GlaxoSmithKline Plc、Grupo Praxis Pharmaceutical SA、Humanigen Inc、Kancera AB、Merck & Co Inc、Novartis AG、Oblita Therapeutics BVBA、Sanofi、）
・シャーガス病薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Chagas Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Chagas Disease Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Chagas Disease Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Chagas Disease Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Chagas Disease Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
AstraZeneca Plc
Bayer AG
Daiichi Sankyo Co Ltd
Eisai Co Ltd
GlaxoSmithKline Plc
Grupo Praxis Pharmaceutical SA
Humanigen Inc
Kancera AB
Merck & Co Inc
Novartis AG
Oblita Therapeutics BVBA
Sanofi

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Cz-007
Cz-008
D-121
DNDI-0690
EPLBS-1246
EPLBS-967
Others

Segment by Application
Hospital
Clinic
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Chagas Disease Drug
1.1 Definition of Chagas Disease Drug
1.2 Chagas Disease Drug Segment by Type
1.2.1 Global Chagas Disease Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Cz-007
1.2.3 Cz-008
1.2.4 D-121
1.2.5 DNDI-0690
1.2.6 EPLBS-1246
1.2.7 EPLBS-967
1.2.8 Others
1.3 Chagas Disease Drug Segment by Applications
1.3.1 Global Chagas Disease Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Chagas Disease Drug Overall Market
1.4.1 Global Chagas Disease Drug Revenue (2014-2025)
1.4.2 Global Chagas Disease Drug Production (2014-2025)
1.4.3 North America Chagas Disease Drug Status and Prospect (2014-2025)
1.4.4 Europe Chagas Disease Drug Status and Prospect (2014-2025)
1.4.5 China Chagas Disease Drug Status and Prospect (2014-2025)
1.4.6 Japan Chagas Disease Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Chagas Disease Drug Status and Prospect (2014-2025)
1.4.8 India Chagas Disease Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Chagas Disease Drug
2.3 Manufacturing Process Analysis of Chagas Disease Drug
2.4 Industry Chain Structure of Chagas Disease Drug

3 Development and Manufacturing Plants Analysis of Chagas Disease Drug
3.1 Capacity and Commercial Production Date
3.2 Global Chagas Disease Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Chagas Disease Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Chagas Disease Drug Production and Capacity Analysis
4.2 Chagas Disease Drug Revenue Analysis
4.3 Chagas Disease Drug Price Analysis
4.4 Market Concentration Degree

5 Chagas Disease Drug Regional Market Analysis
5.1 Chagas Disease Drug Production by Regions
5.1.1 Global Chagas Disease Drug Production by Regions
5.1.2 Global Chagas Disease Drug Revenue by Regions
5.2 Chagas Disease Drug Consumption by Regions
5.3 North America Chagas Disease Drug Market Analysis
5.3.1 North America Chagas Disease Drug Production
5.3.2 North America Chagas Disease Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Chagas Disease Drug Import and Export
5.4 Europe Chagas Disease Drug Market Analysis
5.4.1 Europe Chagas Disease Drug Production
5.4.2 Europe Chagas Disease Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Chagas Disease Drug Import and Export
5.5 China Chagas Disease Drug Market Analysis
5.5.1 China Chagas Disease Drug Production
5.5.2 China Chagas Disease Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Chagas Disease Drug Import and Export
5.6 Japan Chagas Disease Drug Market Analysis
5.6.1 Japan Chagas Disease Drug Production
5.6.2 Japan Chagas Disease Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Chagas Disease Drug Import and Export
5.7 Southeast Asia Chagas Disease Drug Market Analysis
5.7.1 Southeast Asia Chagas Disease Drug Production
5.7.2 Southeast Asia Chagas Disease Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Chagas Disease Drug Import and Export
5.8 India Chagas Disease Drug Market Analysis
5.8.1 India Chagas Disease Drug Production
5.8.2 India Chagas Disease Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Chagas Disease Drug Import and Export

6 Chagas Disease Drug Segment Market Analysis (by Type)
6.1 Global Chagas Disease Drug Production by Type
6.2 Global Chagas Disease Drug Revenue by Type
6.3 Chagas Disease Drug Price by Type

7 Chagas Disease Drug Segment Market Analysis (by Application)
7.1 Global Chagas Disease Drug Consumption by Application
7.2 Global Chagas Disease Drug Consumption Market Share by Application (2014-2019)

8 Chagas Disease Drug Major Manufacturers Analysis
8.1 AstraZeneca Plc
8.1.1 AstraZeneca Plc Chagas Disease Drug Production Sites and Area Served
8.1.2 AstraZeneca Plc Product Introduction, Application and Specification
8.1.3 AstraZeneca Plc Chagas Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Bayer AG
8.2.1 Bayer AG Chagas Disease Drug Production Sites and Area Served
8.2.2 Bayer AG Product Introduction, Application and Specification
8.2.3 Bayer AG Chagas Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Daiichi Sankyo Co Ltd
8.3.1 Daiichi Sankyo Co Ltd Chagas Disease Drug Production Sites and Area Served
8.3.2 Daiichi Sankyo Co Ltd Product Introduction, Application and Specification
8.3.3 Daiichi Sankyo Co Ltd Chagas Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Eisai Co Ltd
8.4.1 Eisai Co Ltd Chagas Disease Drug Production Sites and Area Served
8.4.2 Eisai Co Ltd Product Introduction, Application and Specification
8.4.3 Eisai Co Ltd Chagas Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 GlaxoSmithKline Plc
8.5.1 GlaxoSmithKline Plc Chagas Disease Drug Production Sites and Area Served
8.5.2 GlaxoSmithKline Plc Product Introduction, Application and Specification
8.5.3 GlaxoSmithKline Plc Chagas Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Grupo Praxis Pharmaceutical SA
8.6.1 Grupo Praxis Pharmaceutical SA Chagas Disease Drug Production Sites and Area Served
8.6.2 Grupo Praxis Pharmaceutical SA Product Introduction, Application and Specification
8.6.3 Grupo Praxis Pharmaceutical SA Chagas Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Humanigen Inc
8.7.1 Humanigen Inc Chagas Disease Drug Production Sites and Area Served
8.7.2 Humanigen Inc Product Introduction, Application and Specification
8.7.3 Humanigen Inc Chagas Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Kancera AB
8.8.1 Kancera AB Chagas Disease Drug Production Sites and Area Served
8.8.2 Kancera AB Product Introduction, Application and Specification
8.8.3 Kancera AB Chagas Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Merck & Co Inc
8.9.1 Merck & Co Inc Chagas Disease Drug Production Sites and Area Served
8.9.2 Merck & Co Inc Product Introduction, Application and Specification
8.9.3 Merck & Co Inc Chagas Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Novartis AG
8.10.1 Novartis AG Chagas Disease Drug Production Sites and Area Served
8.10.2 Novartis AG Product Introduction, Application and Specification
8.10.3 Novartis AG Chagas Disease Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Oblita Therapeutics BVBA
8.12 Sanofi

9 Development Trend of Analysis of Chagas Disease Drug Market
9.1 Global Chagas Disease Drug Market Trend Analysis
9.1.1 Global Chagas Disease Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Chagas Disease Drug Regional Market Trend
9.2.1 North America Chagas Disease Drug Forecast 2019-2025
9.2.2 Europe Chagas Disease Drug Forecast 2019-2025
9.2.3 China Chagas Disease Drug Forecast 2019-2025
9.2.4 Japan Chagas Disease Drug Forecast 2019-2025
9.2.5 Southeast Asia Chagas Disease Drug Forecast 2019-2025
9.2.6 India Chagas Disease Drug Forecast 2019-2025
9.3 Chagas Disease Drug Market Trend (Product Type)
9.4 Chagas Disease Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Chagas Disease Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Chagas Disease Drug
Table Global Chagas Disease Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Chagas Disease Drug Production Market Share by Types in 2018
Figure Cz-007 Product Picture
Figure Cz-008 Product Picture
Figure D-121 Product Picture
Figure DNDI-0690 Product Picture
Figure EPLBS-1246 Product Picture
Figure EPLBS-967 Product Picture
Figure Others Product Picture
Table Global Chagas Disease Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Chagas Disease Drug Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Others
Figure Global Chagas Disease Drug Revenue (Million USD) (2014-2025)
Figure Global Chagas Disease Drug Production (K Pcs) (2014-2025)
Figure North America Chagas Disease Drug Market Size (Million USD) (2014-2025)
Figure Europe Chagas Disease Drug Market Size (Million USD) (2014-2025)
Figure China Chagas Disease Drug Market Size (Million USD) (2014-2025)
Figure Japan Chagas Disease Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Chagas Disease Drug Market Size (Million USD) (2014-2025)
Figure India Chagas Disease Drug Market Size (Million USD) (2014-2025)
Table Chagas Disease Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Chagas Disease Drug in 2018
Figure Manufacturing Process Analysis of Chagas Disease Drug
Figure Industry Chain Structure of Chagas Disease Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Chagas Disease Drug Manufacturing Plants Distribution
Table Chagas Disease Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Chagas Disease Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Chagas Disease Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Chagas Disease Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Chagas Disease Drug Production Share by Manufacturers in 2018
Table Chagas Disease Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Chagas Disease Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Chagas Disease Drug Revenue Share by Manufacturers in 2018
Table Chagas Disease Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Chagas Disease Drug Production by Regions 2014-2019 (K Pcs)
Table Global Chagas Disease Drug Production Market Share by Regions 2014-2019
Figure Global Chagas Disease Drug Production Market Share by Regions in 2018
Table Global Chagas Disease Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Chagas Disease Drug Revenue Market Share by Regions 2014-2019
Figure Global Chagas Disease Drug Revenue Market Share by Regions in 2018
Table Global Chagas Disease Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Chagas Disease Drug Consumption Market Share by Regions 2014-2019
Figure North America Chagas Disease Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Chagas Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Chagas Disease Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Chagas Disease Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Chagas Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Chagas Disease Drug Production, Consumption Import and Export (K Pcs)
Figure China Chagas Disease Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Chagas Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Chagas Disease Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Chagas Disease Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Chagas Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Chagas Disease Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Chagas Disease Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Chagas Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Chagas Disease Drug Production, Consumption Import and Export (K Pcs)
Figure India Chagas Disease Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Chagas Disease Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Chagas Disease Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Chagas Disease Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Chagas Disease Drug Market Share by Application (2014-2019)
Table AstraZeneca Plc Chagas Disease Drug Production Sites and Area Served
Table AstraZeneca Plc Chagas Disease Drug Product Introduction, Application and Specification
Table AstraZeneca Plc Chagas Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table AstraZeneca Plc Chagas Disease Drug Production Growth Rate (2014-2019)
Table AstraZeneca Plc Chagas Disease Drug Production Market Share (2014-2019)
Figure AstraZeneca Plc Chagas Disease Drug Revenue Market Share (2014-2019)
Table AstraZeneca Plc Chagas Disease Drug Main Business and Markets Served
Table Bayer AG Chagas Disease Drug Production Sites and Area Served
Table Bayer AG Chagas Disease Drug Product Introduction, Application and Specification
Table Bayer AG Chagas Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bayer AG Chagas Disease Drug Production Growth Rate (2014-2019)
Table Bayer AG Chagas Disease Drug Production Market Share (2014-2019)
Figure Bayer AG Chagas Disease Drug Revenue Market Share (2014-2019)
Table Bayer AG Chagas Disease Drug Main Business and Markets Served
Table Daiichi Sankyo Co Ltd Chagas Disease Drug Production Sites and Area Served
Table Daiichi Sankyo Co Ltd Chagas Disease Drug Product Introduction, Application and Specification
Table Daiichi Sankyo Co Ltd Chagas Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Daiichi Sankyo Co Ltd Chagas Disease Drug Production Growth Rate (2014-2019)
Table Daiichi Sankyo Co Ltd Chagas Disease Drug Production Market Share (2014-2019)
Figure Daiichi Sankyo Co Ltd Chagas Disease Drug Revenue Market Share (2014-2019)
Table Daiichi Sankyo Co Ltd Chagas Disease Drug Main Business and Markets Served
Table Eisai Co Ltd Chagas Disease Drug Production Sites and Area Served
Table Eisai Co Ltd Chagas Disease Drug Product Introduction, Application and Specification
Table Eisai Co Ltd Chagas Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eisai Co Ltd Chagas Disease Drug Production Growth Rate (2014-2019)
Table Eisai Co Ltd Chagas Disease Drug Production Market Share (2014-2019)
Figure Eisai Co Ltd Chagas Disease Drug Revenue Market Share (2014-2019)
Table Eisai Co Ltd Chagas Disease Drug Main Business and Markets Served
Table GlaxoSmithKline Plc Chagas Disease Drug Production Sites and Area Served
Table GlaxoSmithKline Plc Chagas Disease Drug Product Introduction, Application and Specification
Table GlaxoSmithKline Plc Chagas Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table GlaxoSmithKline Plc Chagas Disease Drug Production Growth Rate (2014-2019)
Table GlaxoSmithKline Plc Chagas Disease Drug Production Market Share (2014-2019)
Figure GlaxoSmithKline Plc Chagas Disease Drug Revenue Market Share (2014-2019)
Table GlaxoSmithKline Plc Chagas Disease Drug Main Business and Markets Served
Table Grupo Praxis Pharmaceutical SA Chagas Disease Drug Production Sites and Area Served
Table Grupo Praxis Pharmaceutical SA Chagas Disease Drug Product Introduction, Application and Specification
Table Grupo Praxis Pharmaceutical SA Chagas Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Grupo Praxis Pharmaceutical SA Chagas Disease Drug Production Growth Rate (2014-2019)
Table Grupo Praxis Pharmaceutical SA Chagas Disease Drug Production Market Share (2014-2019)
Figure Grupo Praxis Pharmaceutical SA Chagas Disease Drug Revenue Market Share (2014-2019)
Table Grupo Praxis Pharmaceutical SA Chagas Disease Drug Main Business and Markets Served
Table Humanigen Inc Chagas Disease Drug Production Sites and Area Served
Table Humanigen Inc Chagas Disease Drug Product Introduction, Application and Specification
Table Humanigen Inc Chagas Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Humanigen Inc Chagas Disease Drug Production Growth Rate (2014-2019)
Table Humanigen Inc Chagas Disease Drug Production Market Share (2014-2019)
Figure Humanigen Inc Chagas Disease Drug Revenue Market Share (2014-2019)
Table Humanigen Inc Chagas Disease Drug Main Business and Markets Served
Table Kancera AB Chagas Disease Drug Production Sites and Area Served
Table Kancera AB Chagas Disease Drug Product Introduction, Application and Specification
Table Kancera AB Chagas Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Kancera AB Chagas Disease Drug Production Growth Rate (2014-2019)
Table Kancera AB Chagas Disease Drug Production Market Share (2014-2019)
Figure Kancera AB Chagas Disease Drug Revenue Market Share (2014-2019)
Table Kancera AB Chagas Disease Drug Main Business and Markets Served
Table Merck & Co Inc Chagas Disease Drug Production Sites and Area Served
Table Merck & Co Inc Chagas Disease Drug Product Introduction, Application and Specification
Table Merck & Co Inc Chagas Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Merck & Co Inc Chagas Disease Drug Production Growth Rate (2014-2019)
Table Merck & Co Inc Chagas Disease Drug Production Market Share (2014-2019)
Figure Merck & Co Inc Chagas Disease Drug Revenue Market Share (2014-2019)
Table Merck & Co Inc Chagas Disease Drug Main Business and Markets Served
Table Novartis AG Chagas Disease Drug Production Sites and Area Served
Table Novartis AG Chagas Disease Drug Product Introduction, Application and Specification
Table Novartis AG Chagas Disease Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Novartis AG Chagas Disease Drug Production Growth Rate (2014-2019)
Table Novartis AG Chagas Disease Drug Production Market Share (2014-2019)
Figure Novartis AG Chagas Disease Drug Revenue Market Share (2014-2019)
Table Novartis AG Chagas Disease Drug Main Business and Markets Served
Table Oblita Therapeutics BVBA Chagas Disease Drug Production Sites and Area Served
Table Sanofi Chagas Disease Drug Production Sites and Area Served
Figure Global Chagas Disease Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Chagas Disease Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Chagas Disease Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Chagas Disease Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Chagas Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Chagas Disease Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Chagas Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Chagas Disease Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Chagas Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Chagas Disease Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Chagas Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Chagas Disease Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Chagas Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Chagas Disease Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Chagas Disease Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Chagas Disease Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Chagas Disease Drug by Application (2019-2025)
Table Chagas Disease Drug Distributors List
Table Chagas Disease Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

AstraZeneca Plc、Bayer AG、Daiichi Sankyo Co Ltd、Eisai Co Ltd、GlaxoSmithKline Plc、Grupo Praxis Pharmaceutical SA、Humanigen Inc、Kancera AB、Merck & Co Inc、Novartis AG、Oblita Therapeutics BVBA、Sanofi、

★調査レポート[世界のシャーガス病薬市場 2019年] (コード：DATA909X05349)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のシャーガス病薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のクローン病薬市場 2019年
    DATA909X06111 / QYResearch / 2019年11月15日 / ※本調査レポートは、クローン病薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アミノサリチル酸（5-ASA）、コルチコステロイド、免疫調節薬、抗生物質に、用途別には、寛解の達成（症状の欠如）、寛解の維持（再燃の予防）、小児クローン病にセグメント区分し、クローン病薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・クローン病薬の世界市場概要 ・クローン病薬の製造コスト構成分析 ・クローン病薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・クローン病薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・クローン病薬のセグメント分析（種類別） （アミノサリチル酸（5-ASA）、コルチコステロイド、免疫調節薬、抗生物質）...The global Crohn’s Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Crohn’s Disease Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Crohn’s Disease Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Crohn’s Disease Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のデビック病薬市場 2019年
    DATA909X06374 / QYResearch / 2019年11月15日 / ※本調査レポートは、デビック病薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、グルココルチコイド、免疫グロブリン、その他に、用途別には、病院、診療所、その他にセグメント区分し、デビック病薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・デビック病薬の世界市場概要 ・デビック病薬の製造コスト構成分析 ・デビック病薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・デビック病薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・デビック病薬のセグメント分析（種類別） （グルココルチコイド、免疫グロブリン、その他）...The global Devic's Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Devic's Disease Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Devic's Disease Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Devic's Disease Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の胃食道逆流症（GERD）薬市場 2019年
    DATA909X08375 / QYResearch / 2019年11月15日 / ※本調査レポートは、胃食道逆流症（GERD）薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、H2受容体拮抗薬、プロトンポンプ阻害薬（PPi）、制酸薬に、用途別には、病院、診療所、医療センター、その他にセグメント区分し、胃食道逆流症（GERD）薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・胃食道逆流症（GERD）薬の世界市場概要 ・胃食道逆流症（GERD）薬の製造コスト構成分析 ・胃食道逆流症（GERD）薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・胃食道逆流症（GERD）薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・胃食道逆流症（GERD）薬のセグメント分析（種類別） （H2受容体拮抗薬、プロトンポンプ阻害薬（PPi）、制酸薬）...The global Gastro Esophageal Reflux Disease (GERD) Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Gastro Esophageal Reflux Disease (GERD) Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Gastro Esophageal Reflux Disease (GERD) Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Gastro Esophageal Reflux Disease (GERD) Drug in North America, Europe, China,...
  • 世界のセリアック病治療薬市場 2019年
    DATA909X05241 / QYResearch / 2019年11月15日 / ※本調査レポートは、セリアック病治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、膨満感、下痢、食欲不振、その他に、用途別には、治療の第一線、治療の第二線にセグメント区分し、セリアック病治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・セリアック病治療薬の世界市場概要 ・セリアック病治療薬の製造コスト構成分析 ・セリアック病治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・セリアック病治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・セリアック病治療薬のセグメント分析（種類別） （膨満感、下痢、食欲不振、その他）...The global Celiac Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Celiac Disease Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Celiac Disease Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Celiac Disease Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のパーキンソン病薬市場 2019年
    DATA909X12634 / QYResearch / 2019年11月20日 / ※本調査レポートは、パーキンソン病薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、シネメット-CR、トラスター、マドパル、COMT阻害剤、その他に、用途別には、40歳未満、40-65歳、65歳以上にセグメント区分し、パーキンソン病薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・パーキンソン病薬の世界市場概要 ・パーキンソン病薬の製造コスト構成分析 ・パーキンソン病薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・パーキンソン病薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・パーキンソン病薬のセグメント分析（種類別） （シネメット-CR、トラスター、マドパル、COMT阻害剤、その他）...The global Parkinson's Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Parkinson's Disease Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Parkinson's Disease Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Parkinson's Disease Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の鎌状赤血球症薬市場 2019年
    DATA909X15027 / QYResearch / 2019年11月20日 / ※本調査レポートは、鎌状赤血球症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ARQ-092、BIVV-003、CAL-H、CTX-001、DRX-194、その他に、用途別には、病院、診療所、その他にセグメント区分し、鎌状赤血球症薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・鎌状赤血球症薬の世界市場概要 ・鎌状赤血球症薬の製造コスト構成分析 ・鎌状赤血球症薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・鎌状赤血球症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・鎌状赤血球症薬のセグメント分析（種類別） （ARQ-092、BIVV-003、CAL-H、CTX-001、DRX-194、その他）...The global Sickle Cell Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Sickle Cell Disease Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Sickle Cell Disease Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Sickle Cell Disease Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の胃食道逆流症治療薬及び装置市場 2019年
    DATA909X08376 / QYResearch / 2019年11月15日 / ※本調査レポートは、胃食道逆流症治療薬及び装置の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、Medigus超音波手術用エンドステープラー、LINX管理システム、Stretta療法、Bravo逆流試験システム、Digitrapper逆流試験システム、その他に、用途別には、病院、診療所、その他にセグメント区分し、胃食道逆流症治療薬及び装置の世界市場を分析しました。 ・エグゼクティブ・サマリー ・胃食道逆流症治療薬及び装置の世界市場概要 ・胃食道逆流症治療薬及び装置の製造コスト構成分析 ・胃食道逆流症治療薬及び装置の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・胃食道逆流症治療薬及び装置の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・胃食道逆流症治療薬及び装置のセグメント分析（種類別） （Medigus超音波手術用エンドステープラー、LINX管理システム、Stretta療法、Bravo逆流試験システム、Digitrapper逆流試験システム、その他）...The global Gastro Esophageal Reflux Disease Drug and Devices market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Gastro Esophageal Reflux Disease Drug and Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Gastro Esophageal Reflux Disease Drug and Devices market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Gastro Esophageal Reflux Disease Drug and Devices in...
  • 世界の併用療法薬市場 2019年
    DATA909X05664 / QYResearch / 2019年11月15日 / ※本調査レポートは、併用療法薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、グリチルリチン酸二アンモニウム、インターフェロンおよびヌクレオシド薬、標的療法薬、その他に、用途別には、がん、心血管疾患、免疫疾患にセグメント区分し、併用療法薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・併用療法薬の世界市場概要 ・併用療法薬の製造コスト構成分析 ・併用療法薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・併用療法薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・併用療法薬のセグメント分析（種類別） （グリチルリチン酸二アンモニウム、インターフェロンおよびヌクレオシド薬、標的療法薬、その他）...The global Combination Therapy Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Combination Therapy Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Combination Therapy Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Combination Therapy Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆